Tenecteplase Pulmonary Embolism Italian Study
A Phase II Multicenter, Randomized, Double Blind Study Comparing the Efficacy and Safety of Single Bolus i.v. Tenecteplase Versus Placebo in Normotensive Patients With Pulmonary Embolism and Right Ventricular Dysfunction
Sponsor: University Of Perugia
Terminated
competitor study about to start
Other terminated trials from University Of Perugia
Other Pulmonary Embolism trials with similar outcome
This PHASE2 trial investigates Pulmonary Embolism and is currently terminated or withdrawn. University Of Perugia leads this study, which shows 6 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Jul 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Of Perugia
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Ancona, Italy , Bari, Italy , Bologna, Italy , Brescia, Italy , Caserta, Italy , Desio, Italy , Florence, Italy , Genova, Italy , Lagosanto, Italy , Legnano, Italy and 13 more locations